Clinical Trials Directory

Trials / Completed

CompletedNCT04187274

Evaluation of the IKORUS Technology in Patients Undergoing Major Abdominal Surgery

Evaluation of the Urethral Photoplethysmography-derived Perfusion Device (IKORUS) in Patients Undergoing Major Abdominal Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Erasme University Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational substudy is to evaluate the feasibility, performance and behavior of the IKORUS (Advanced Perfusion Diagnostics, Villeurbanne, France), a new tissue perfusion device using urethral photoplethysmography in patients undergoing major abdominal surgery and in whom an advanced hemodynamic monitoring is placed.

Detailed description

Continuous monitoring of tissue perfusion in patients undergoing major surgery remains challenging because of the lack of tools available. Through using urethral photoplethysmography, the urethral perfusion index (uPI) could allow tissue perfusion monitoring through a modified urinary catheter. The goal of this observational study is to evaluate the feasibility , performance and behavior of the IKORUS (Advanced Perfusion Diagnostics, Villeurbanne, France), a new device in the field. We aimed to assess its performance (duration and signal quality), the uPI variations during hemodynamic events (fluid challenge) in patients undergoing major abdominal surgery and equipped with an advanced hemodynamic monitoring.

Conditions

Interventions

TypeNameDescription
DEVICEIKORUS technologyIkorus technology is a new micro perfusion device measuring via urethral photoplethysmography, the urethral perfusion index (uPI) in patients equipped with an urinary catheter.

Timeline

Start date
2019-09-04
Primary completion
2020-07-30
Completion
2020-07-30
First posted
2019-12-05
Last updated
2020-09-22

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04187274. Inclusion in this directory is not an endorsement.